Pulmonology status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 50: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Joanna Ekabua | | style="padding: 5px 5px; background: #F5F5F5;" |Joanna Ekabua | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Roukoz | | style="padding: 5px 5px; background: #F5F5F5;" |Roukoz | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Complete | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 242: | Line 242: | ||
|- | |- | ||
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Pulmonology | | rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Pulmonology | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Decompression sickness | | style="padding: 5px 5px; background: #F5F5F5;" |[[Decompression sickness]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |In progress | | style="padding: 5px 5px; background: #F5F5F5;" |In progress | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hazem | | style="padding: 5px 5px; background: #F5F5F5;" |Hazem | ||
| Line 250: | Line 250: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Air embolism | | style="padding: 5px 5px; background: #F5F5F5;" |[[Air embolism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mounika Lakumalla | | style="padding: 5px 5px; background: #F5F5F5;" |Mounika Lakumalla | ||
| Line 258: | Line 258: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hepatopulmonary syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hepatopulmonary syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |In progress | | style="padding: 5px 5px; background: #F5F5F5;" |In progress | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush | | style="padding: 5px 5px; background: #F5F5F5;" |Soroush | ||
| Line 266: | Line 266: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Tracheitis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Tracheitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |In progress | | style="padding: 5px 5px; background: #F5F5F5;" |In progress | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Rija Gul | | style="padding: 5px 5px; background: #F5F5F5;" |Rija Gul | ||
| Line 275: | Line 275: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pneumoconiosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |In progress | | style="padding: 5px 5px; background: #F5F5F5;" |In progress | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hadeel | | style="padding: 5px 5px; background: #F5F5F5;" |Hadeel | ||
| Line 283: | Line 283: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Berylliosis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Berylliosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |In progress | | style="padding: 5px 5px; background: #F5F5F5;" |In progress | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Omid | | style="padding: 5px 5px; background: #F5F5F5;" |Omid | ||
| Line 461: | Line 461: | ||
|- | |- | ||
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Pulmonology | | rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Pulmonology | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cystic fibrosis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 469: | Line 469: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Pulmonary hypertension | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pulmonary hypertension]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 477: | Line 477: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Respiratory failure | | style="padding: 5px 5px; background: #F5F5F5;" |[[Respiratory failure]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 486: | Line 486: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Pulmonary edema | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pulmonary edema]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 494: | Line 494: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Neurogenic pulmonary edema | | style="padding: 5px 5px; background: #F5F5F5;" |[[Neurogenic pulmonary edema]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 503: | Line 503: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Bronchiectasis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Bronchiectasis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 512: | Line 512: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hemoptysis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hemoptysis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 521: | Line 521: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Occupational lung disease | | style="padding: 5px 5px; background: #F5F5F5;" |[[Occupational lung disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 530: | Line 530: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Restrictive lung disease | | style="padding: 5px 5px; background: #F5F5F5;" |[[Restrictive lung disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 539: | Line 539: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Obstructive lung disease | | style="padding: 5px 5px; background: #F5F5F5;" |[[Obstructive lung disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 548: | Line 548: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Interstitial lung disease | | style="padding: 5px 5px; background: #F5F5F5;" |[[Interstitial lung disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 557: | Line 557: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Pneumothorax | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pneumothorax]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 566: | Line 566: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hypersensitivity pneumonitis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hypersensitivity pneumonitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 575: | Line 575: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Non small cell lung cancer | | style="padding: 5px 5px; background: #F5F5F5;" |[[Non small cell lung cancer]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 584: | Line 584: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Adenocarcinoma | | style="padding: 5px 5px; background: #F5F5F5;" |[[Adenocarcinoma of the lung|Adenocarcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 593: | Line 593: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Large cell carcinoma | | style="padding: 5px 5px; background: #F5F5F5;" |[[Large cell carcinoma of the lung|Large cell carcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 602: | Line 602: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Squamous cell carcinoma | | style="padding: 5px 5px; background: #F5F5F5;" |[[Squamous cell carcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 611: | Line 611: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Lung mass | | style="padding: 5px 5px; background: #F5F5F5;" |[[Lung mass]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 620: | Line 620: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cyanosis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cyanosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 629: | Line 629: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Respiratory acidosis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Respiratory acidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 638: | Line 638: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Respiratory alkalosis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Respiratory alkalosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 647: | Line 647: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Diaphragmatic paralysis | | style="padding: 5px 5px; background: #F5F5F5;" |[[Diaphragmatic paralysis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 654: | Line 654: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| | |||
|[[Bronchogenic cyst]] | |||
|Assigned | |||
|Joanna Ekabua | |||
|Roukoz | |||
|Complete | |||
| | |||
|- | |- | ||
|} | |} | ||
Revision as of 02:27, 22 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
System leader: Roukoz Abou Karam, M.D.
| Progress | |
|---|---|
| Completed | |
| In progress | |
| Remaining | |
List of Chapters Requiring Content
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Pulmonolgy | Amniotic fluid embolism | ||||||
| Bronchoscopy | |||||||
| Bronchogenic cyst | Assigned | Joanna Ekabua | Roukoz | Complete | |||
| Chylothorax | |||||||
| Farmer's lung | Assigned | Aisha | Ali Musadiq | ||||
| Flock worker's lung | |||||||
| Hepatopulmonary syndrome | |||||||
| Hydrothorax | |||||||
| Hypoxemia | |||||||
| Mediastinal disorders | |||||||
| Mediastinal masses | |||||||
| Pleural disorders | |||||||
| Pleural plaque | |||||||
| Pleurodynia | |||||||
| Pressure associated lung diseases | |||||||
| Altitude sickness | |||||||
| Barotrauma | |||||||
| Decompression sickness | Assigned | Jaspinder Kaur | Ahmed Elsaiey | ||||
| Nitrogen narcosis | |||||||
| Pulmonary function tests | |||||||
| Pulmonary nodule | |||||||
In progress chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Pulmonology | Decompression sickness | In progress | Hazem | ||||
| Air embolism | Assigned | Mounika Lakumalla | Ahmed Elsaiey | ||||
| Hepatopulmonary syndrome | In progress | Soroush | |||||
| Tracheitis | In progress | Rija Gul | |||||
| Pneumoconiosis | In progress | Hadeel | |||||
| Berylliosis | In progress | Omid | |||||
Completed chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Pulmonology | Cystic fibrosis | ||||||
| Pulmonary hypertension | |||||||
| Respiratory failure | |||||||
| Pulmonary edema | |||||||
| Neurogenic pulmonary edema | |||||||
| Bronchiectasis | |||||||
| Hemoptysis | |||||||
| Occupational lung disease | |||||||
| Restrictive lung disease | |||||||
| Obstructive lung disease | |||||||
| Interstitial lung disease | |||||||
| Pneumothorax | |||||||
| Hypersensitivity pneumonitis | |||||||
| Non small cell lung cancer | |||||||
| Adenocarcinoma | |||||||
| Large cell carcinoma | |||||||
| Squamous cell carcinoma | |||||||
| Lung mass | |||||||
| Cyanosis | |||||||
| Respiratory acidosis | |||||||
| Respiratory alkalosis | |||||||
| Diaphragmatic paralysis | |||||||
| Bronchogenic cyst | Assigned | Joanna Ekabua | Roukoz | Complete |